News | March 01, 2021
Accelerated growth in pharma depends on the right policies: Experts
A mix of favorable government policies and a positive environment will create a win-win situation for all stakeholders
A mix of favorable government policies and a positive environment will create a win-win situation for all stakeholders
_256_384.jpg)
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
DHL and other logistics companies were already transporting pharmaceutical products at minus 70°C in Schaumaplast boxes packed with dry ice before the coronavirus pandemic
posaconazole delayed-release tablets 100 mg are the generic equivalent of Noxafil.
The jump in profit is due to the better performance of the API business.
Be One is a 100% Ayurvedic health and wellness supplement.
With cost optimization leading to cumulative savings of US $80 million over last 8 years, the company now aims to tap bigger opportunities in generics business
Subscribe To Our Newsletter & Stay Updated
